Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Michael

Showing results (741-750 of 769) with videos related to

Pageof 77
Sort By:
Rheumatology (Oxford, England)|June 12, 2023
Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registryGustavo G M Balbi, Yasaman Ahmadzadeh, Maria G Tektonidou, et al.
Journal of Biomolecular Techniques : JBT|March 9, 2006
The SNPlex genotyping system: a flexible and scalable platform for SNP genotypingAndreas R Tobler, Sabine Short, Mark R Andersen, et al.
Lupus Science & Medicine|August 14, 2021
Safety of procuring research tissue during a clinically indicated kidney biopsy from patients with lupus: data from the Accelerating Medicines Partnership RA/SLE NetworkKristina K Deonaraine, Philip M Carlucci, Andrea Fava, et al.
Journal of Thrombosis and Haemostasis : JTH|August 1, 2019
Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repositoryMaria Efthymiou, Ian J Mackie, Philip J Lane, et al.
JCI Insight|January 23, 2024
Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritisAndrea Fava, Jill Buyon, Laurence Magder, et al.
BMC Genomics|March 3, 2017
Unity in defence: honeybee workers exhibit conserved molecular responses to diverse pathogensVincent Doublet, Yvonne Poeschl, Andreas Gogol-Döring, et al.
Lupus|October 7, 2022
Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry")Zeynep B Erton, Rebecca K Leaf, Danieli de Andrade, et al.
Seminars in Arthritis and Rheumatism|June 3, 2019
The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohortMassimo Radin, Savino Sciascia, Doruk Erkan, et al.
Nature|February 25, 2026
Cavity-altered superconductivityItai Keren, Tatiana A Webb, Shuai Zhang, et al.
Cell Stem Cell|March 12, 2019
MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In VivoLorna R Fiedler, Kathryn Chapman, Min Xie, et al.
Pageof 77

Showing results (741-750 of 769) with videos related to

Sort By:
Pageof 77
Rheumatology (Oxford, England)|June 12, 2023
Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registryGustavo G M Balbi, Yasaman Ahmadzadeh, Maria G Tektonidou, et al.
Journal of Biomolecular Techniques : JBT|March 9, 2006
The SNPlex genotyping system: a flexible and scalable platform for SNP genotypingAndreas R Tobler, Sabine Short, Mark R Andersen, et al.
Lupus Science & Medicine|August 14, 2021
Safety of procuring research tissue during a clinically indicated kidney biopsy from patients with lupus: data from the Accelerating Medicines Partnership RA/SLE NetworkKristina K Deonaraine, Philip M Carlucci, Andrea Fava, et al.
Journal of Thrombosis and Haemostasis : JTH|August 1, 2019
Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repositoryMaria Efthymiou, Ian J Mackie, Philip J Lane, et al.
JCI Insight|January 23, 2024
Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritisAndrea Fava, Jill Buyon, Laurence Magder, et al.
BMC Genomics|March 3, 2017
Unity in defence: honeybee workers exhibit conserved molecular responses to diverse pathogensVincent Doublet, Yvonne Poeschl, Andreas Gogol-Döring, et al.
Lupus|October 7, 2022
Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry")Zeynep B Erton, Rebecca K Leaf, Danieli de Andrade, et al.
Seminars in Arthritis and Rheumatism|June 3, 2019
The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohortMassimo Radin, Savino Sciascia, Doruk Erkan, et al.
Nature|February 25, 2026
Cavity-altered superconductivityItai Keren, Tatiana A Webb, Shuai Zhang, et al.
Cell Stem Cell|March 12, 2019
MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In VivoLorna R Fiedler, Kathryn Chapman, Min Xie, et al.
Pageof 77